The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Xenon Pharmaceuticals Inc(NASDAQ:XENE) 
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel modulator that is Phase III clinical trials for the treatment...
Website: http://www.xenon-pharma.com
Founded: 1996
Full Time Employees: 100
Sector: Healthcare
Industry: Biotechnology
Xenon Pharmaceuticals Days Payable Outstanding ttm (DPO)
Xenon Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Xenon Pharmaceuticals Op Cashflow Per Share ttm
Xenon Pharmaceuticals Free Cashflow Per Share ttm
Xenon Pharmaceuticals Cash Per Share ttm
Xenon Pharmaceuticals P/S ratio ttm
Xenon Pharmaceuticals (GAAP) P/E ratio ttm
Xenon Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.